Trial Profile
Safety assessment study of ET-743 in patients with translocation-related sarcomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2016
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary)
- Indications Sarcoma
- Focus Adverse reactions
- Sponsors Taiho Pharmaceutical
- 09 Aug 2016 Status changed from active, no longer recruiting to completed.
- 06 Jun 2016 New trial record